GLUE fund manager activity
Monte Rosa Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q1 2026 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller - Duquesne Family Office | New | 297,600 | $7,202,000 | 0.17% | Aug 14, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 363,520 | $8,797,182 | 0.00% | Aug 4, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | New | 314,862 | $5,179,479 | 0.00% | May 5, 2026 |